These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
772 related articles for article (PubMed ID: 9152373)
41. The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys. Orcullo Santillan MK; Herring J; Hoppensteadt DA; Jeske W; Herbert JM; Fareed J Clin Appl Thromb Hemost; 2001 Jan; 7(1):10-5. PubMed ID: 11190897 [TBL] [Abstract][Full Text] [Related]
42. TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog. Rebello SS; Driscoll EM; Lucchesi BR Stroke; 1997 Sep; 28(9):1789-96. PubMed ID: 9303027 [TBL] [Abstract][Full Text] [Related]
43. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560 [TBL] [Abstract][Full Text] [Related]
44. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist. Moritani Y; Sato K; Shigenaga T; Hisamichi N; Ichihara M; Akamatsu S; Suzuki Ki; Nii T; Kaku S; Kawasaki T; Matsumoto Y; Inagaki O; Tomioka K; Yanagisawa I Eur J Pharmacol; 2002 Mar; 439(1-3):43-52. PubMed ID: 11937091 [TBL] [Abstract][Full Text] [Related]
45. Antithrombotic effect of Z4A5 on coronary thrombosis in a canine model of acute unstable angina. Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Shen XL; Wang YL; Zang WJ; Wang B Br J Pharmacol; 2013 Jun; 169(4):848-59. PubMed ID: 23083032 [TBL] [Abstract][Full Text] [Related]
46. Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery. Umemura K; Nishiyama H; Kikuchi S; Kondo K; Nakashima M Thromb Haemost; 1996 Nov; 76(5):799-806. PubMed ID: 8950793 [TBL] [Abstract][Full Text] [Related]
47. Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs. Ogawa T; Sugidachi A; Naganuma H; Asai F Thromb Res; 2000 Mar; 97(5):307-15. PubMed ID: 10709906 [TBL] [Abstract][Full Text] [Related]
48. Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs. Mousa SA; Mu DX; Lucchesi BR Stroke; 1997 Apr; 28(4):830-5; discussion 835-6. PubMed ID: 9099204 [TBL] [Abstract][Full Text] [Related]
49. The in vitro and in vivo pharmacological profiles of a platelet glycoprotein IIb/IIIa antagonist, NSL-9403. Katada J; Takiguchi Y; Muramatsu M; Fujiyoshi T; Uno I Thromb Res; 1997 Oct; 88(1):27-40. PubMed ID: 9336871 [TBL] [Abstract][Full Text] [Related]
53. The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760. Nichols AJ; Vasko JA; Koster PF; Valocik RE; Rhodes GR; Miller-Stein C; Boppana V; Samanen JM J Pharmacol Exp Ther; 1994 Aug; 270(2):614-21. PubMed ID: 8071853 [TBL] [Abstract][Full Text] [Related]
54. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model. Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458 [TBL] [Abstract][Full Text] [Related]
55. Effect of vintoperol on platelet aggregation and experimental thrombosis. Csomor K; Kárpáti E Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876 [TBL] [Abstract][Full Text] [Related]
56. Effects of TAK-029, a novel GPIIb/IIIa antagonist, on arterial thrombosis in guinea pigs, dogs and monkeys. Kawamura M; Tsuji N; Moriya N; Terashita Z Thromb Res; 1997 May; 86(4):275-85. PubMed ID: 9187016 [TBL] [Abstract][Full Text] [Related]
57. Effect of aspirin on platelet desaggregation induced by SR121566, a potent GP-IIb/IIIa antagonist. Savi P; Bernat A; Lalé A; Roque C; Zamboni G; Herbert JM Platelets; 2000 Feb; 11(1):43-8. PubMed ID: 10938881 [TBL] [Abstract][Full Text] [Related]
58. Prevention of canine coronary artery thrombosis with echistatin, a potent inhibitor of platelet aggregation from the venom of the viper, Echis carinatus. Shebuski RJ; Ramjit DR; Sitko GR; Lumma PK; Garsky VM Thromb Haemost; 1990 Dec; 64(4):576-81. PubMed ID: 2084943 [TBL] [Abstract][Full Text] [Related]
59. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment. Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR J Cardiovasc Pharmacol; 1994 Feb; 23(2):194-202. PubMed ID: 7511747 [TBL] [Abstract][Full Text] [Related]
60. Intravenous and oral antiplatelet/antithrombotic efficacy and specificity of XR300, a novel nonpeptide platelet GPIIb/IIIa antagonist. Mousa SA; Forsythe M; Wityak J; Bozarth J; Mu DX J Cardiovasc Pharmacol; 1998 Mar; 31(3):441-8. PubMed ID: 9514190 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]